Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway

Journal of Ethnopharmacology

Volumn 129, Issue 2, 2010, Pages 273-279

  Li, Xin ^a,b   Du, Jun Rong ^a   Yu, Yan ^a   Bai, Bo ^a   Zheng, Xiao Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

C fos; Intimal hyperplasia; MAPK; Proliferation of smooth muscle cells; Tanshinone IIA

Indexed keywords

BROXURIDINE; DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C FOS; TANSHINONE IIA; ABIETANE DERIVATIVE; PHENANTHRENE DERIVATIVE; PLANT EXTRACT; TANSHINONE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON DILATATION; CAROTID ARTERY INJURY; CELL COUNT; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; CAROTID ARTERY; CAROTID ARTERY INJURIES; CHEMISTRY; CULTURE TECHNIQUE; DRUG EFFECTS; HYPERPLASIA; INTIMA; METABOLISM; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHOSPHORYLATION; SALVIA MILTIORRHIZA; SPRAGUE DAWLEY RAT;

ANGIOPLASTY, BALLOON; ANIMALS; BROMODEOXYURIDINE; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL PROLIFERATION; DNA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYPERPLASIA; MALE; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; PHENANTHRENES; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; TUNICA INTIMA; DITERPENES, ABIETANE;

BOVINAE; RATTUS;

EID: 77952891072     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.03.021     Document Type: Article

References (20)

1. Chen C.Y., Surowiec S.M., Morsy A.H., Ma M.H. Intraperitoneal infusion of homocysteine increases intimal hyperplasia in balloon injured rat carotid arteries. Atherosclerosis 2002, 60:103-144.
2. Cheng T.O. Cardiovascular effects of Danshen. International Journal of Cardiology 2007, 121:9-22.
3. Clows A.W., Reidy M.A., Clows M.M. Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium. Laboratory Investigation 1983, 49:327-333.
4. Du J.R. Inhibition of proliferation of human smooth muscle cells by tanshinone IIA. West China Journal of Pharmaceutical Sciences 1999, 14:1-3.
5. Du J.R., Li X., Zhang R., Qian Z.M. Tanshinone inhibits intimal hyperplasia in the ligated carotid artery in mice. Journal of Ethnopharmacology 2005, 98:319-322.
6. Inoue T., Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circulation Journal 2009, 73:615-621.
7. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., Kutys R., Skorija K., Gold H., Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. Journal of the American College of Cardiology 2006, 48:193-202.
8. Kim D.W., Kwon J.S., Kim Y.G., Kim M.S., Lee G.S., Youn T.J., Cho M.C. Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model. Circulation 2004, 109:1558-1563.
9. Lafont A., Faxon D. Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?. Cardiovascular Research 1998, 39:50-59.
10. Li C.Z., Yang S.C., Zhao F.D. Effect of tanshinone II A sulfonate on thrombus formation, platelet and coagulation in rats and mice. Acta Pharmacology Sinica 1984, 5:39-42.
11. Lin R., Wang W.R., Liu J.T., Yang G.D., Han C.J. Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. Journal of Ethnopharmacology 2006, 108:217-222.
12. Muto A., Fitzgerald T.N., Pimiento J.M., Maloney S.P., Teso D., Paszkowiak J.J., Westvik T.S., Kudo F.A., Nishibe T., Dardik A. Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons. Journal of Vascular Surgery 2007, 45(suppl A):A15-A24.
13. Niu X.L., Ichimori K., Yang X., Hirota Y., Hoshiai K., Li M., Nakazawa H. Tanshinone IIA inhibits low density lipoprotein oxidation in vitro. Free Radical Research 2000, 33:305-312.
14. Portugal L.R., Fernandes L.R., Alvarez-Leite J.I. Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development. Expert Review of Anti-infective Therapy 2009, 7:807-819.
15. Torella D., Curcio A., Gasparr I.C., Galuppo V., Serio D.D., Surace F.C., Cavaliere A.L. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation. American Journal of Physiology. Heart and Circulatory Physiology 2007, 292:H2935-H2943.
16. Wang H., Gao X.M., Zhang B.L. Tanshinone: an inhibitor of proliferation of vascular smooth muscle cells. Journal of Ethnopharmacology 2005, 99:93-98.
17. Xu W., Yang J., Wu L.M. Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Die Pharmazie 2009, 64:332-336.
18. Zhang H.M., Zhuang Q.Q., Li C.Z., Mei M.Z., Yang B.J. The effect of tanshinone II A sulfonate on actin activated Mg2+-ATPase activity in platelets. Journal of Shanghai Medical University 1988, 15:289-292.
19. Zhang W.J., Bao X.F., Wang X.F., Xu M.Y., Qian Z.H. Preventive effect of sodium tanshinone IIA sulfonate on c-myc gene expression stimulated by macrophage-derived growth factor. Chinese Journal of Arteriosclerosis 1996, 4:45-47.
20. Zhou G.Y., Zhao B.L., Hou J.W., Ma G.E., Xin W.J. Protective effects of sodium tanshinone IIA suophonate against adriamycin induced lipid peroxidation in mice hearts in vivo and in vitro. Pharmacological Research 1999, 40:487-491.